RESUMEN
Endothelial injury is related to poor outcomes in respiratory infections yet little is known in relation to COVID-19. Performing a longitudinal analysis (on emergency department admission and post-hospitalisation follow-up), we evaluated endothelial damage via surrogate systemic endothelial biomarkers, that is, proadrenomedullin (proADM) and proendothelin, in patients with COVID-19. Higher proADM and/or proendothelin levels at baseline were associated with the most severe episodes and intensive care unit admission when compared with ward-admitted individuals and outpatients. Elevated levels of proADM or proendothelin at day 1 were associated with in-hospital mortality. High levels maintained after discharge were associated with reduced diffusing capacity.
Asunto(s)
COVID-19 , Biomarcadores , Mortalidad Hospitalaria , Hospitalización , Humanos , Unidades de Cuidados IntensivosAsunto(s)
COVID-19 , Sobrevivientes , COVID-19/psicología , Humanos , Estudios Longitudinales , Calidad de VidaRESUMEN
BACKGROUND: Population-based and retrospective studies have shown that risk for cardiovascular events such as arrythmias, ischemic episodes, or heart failure, increase during and after bronchiectasis exacerbations. RESEARCH QUESTION: What are the risk factors for cardiovascular events (CVE) during and after bronchiectasis exacerbations and their impact on mortality? STUDY DESIGN AND METHODS: This was a post hoc retrospective analysis of a prospective observational study of 250 patients with bronchiectasis at two tertiary care hospitals. Only the first exacerbation was considered for each patient, collecting demographic, comorbidity, and severity data. The main outcomes were the appearance of CVE and mortality. Risk factors for CVE were analyzed using a semi-competing risks model. RESULTS: During a median follow-up of 35 months, 74 (29.6%) patients had a CVE and 93 (37.2%) died. Semi-competing risk analysis indicated that age, arterial hypertension, COPD, and potentially severe exacerbations significantly increased the risk for developing CVE. Compared with patients without CVE, those with CVE had higher mortality. INTERPRETATION: Demographic factors and comorbidities are risk factors for the development of CVE after an acute exacerbation of bronchiectasis. The appearance of CVE worsens long-term prognosis.
Asunto(s)
Bronquiectasia , Enfermedades Cardiovasculares , Enfermedades Cardiovasculares/etiología , Humanos , Pronóstico , Estudios Retrospectivos , Factores de RiesgoAsunto(s)
Enfermedades Bronquiales , Cálculos , Litiasis , Humanos , Litiasis/diagnóstico por imagenRESUMEN
No disponible
Asunto(s)
Humanos , Masculino , Anciano , Bronquiectasia/diagnóstico por imagen , Bronquiectasia/diagnóstico , Bronquiectasia/patología , Tomografía Computarizada de EmisiónRESUMEN
No disponible